Peter Greenleaf
2019 - Avalo Therapeutics
In 2019, Peter Greenleaf earned a total compensation of $735.2K as Former Chief Executive Officer and former Principal Executive Officer at Avalo Therapeutics, a 86% decrease compared to previous year.
Compensation breakdown
Salary | $175,750 |
---|---|
Other | $559,454 |
Total | $735,204 |
Greenleaf received $559.5K in other compensation, accounting for 76% of the total pay in 2019.
Greenleaf also received $175.8K in salary.
Rankings
In 2019, Peter Greenleaf's compensation ranked 10,530th out of 13,971 executives tracked by ExecPay. In other words, Greenleaf earned more than 24.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,530 | 25th |
Manufacturing | 4,259 | 25th |
Chemicals And Allied Products | 1,650 | 25th |
Drugs | 1,413 | 25th |
Pharmaceutical Preparations | 1,048 | 25th |
Greenleaf's colleagues
We found three more compensation records of executives who worked with Peter Greenleaf at Avalo Therapeutics in 2019.
News
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
April 18, 2022
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
May 10, 2021
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019